CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
3.560
+0.150 (4.40%)
Jul 9, 2026, 2:35 PM EDT - Market open
CervoMed Market Cap
CervoMed has a market cap or net worth of $48.15 million as of July 9, 2026. Its market cap has decreased by -18.75% in one year.
Market Cap
48.15M
Enterprise Value
33.20M
1-Year Change
-18.75%
Ranking
Category
Stock Price
$3.56
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has increased from $43.26M to $48.15M, an increase of 11.30%. That is a compound annual growth rate of 3.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 48.15M | -34.12% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mereo BioPharma Group | 50.44M |
| Eloxx Pharmaceuticals | 49.44M |
| Radiopharm Theranostics | 49.00M |
| Impact BioMedical | 48.70M |
| Metagenomi Therapeutics | 48.56M |
| Dogwood Therapeutics | 47.42M |
| Tvardi Therapeutics | 46.91M |
| PDS Biotechnology | 46.04M |